PRFX
Painreform Ltd
NASDAQ: PRFX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.88
-7.84% today
Updated 2026-04-29
Market cap
$1.72M
P/E ratio
—
P/S ratio
101.35x
EPS (TTM)
$-7.47
Dividend yield
—
52W range
$2 – $12
Volume
0.6M
Painreform Ltd (PRFX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-870000.00 | $-635000.00 | $-609000.00 | $-2.56M | $-6.55M | $-6.46M | $-6.68M | $-12.62M | $-3.96M |
| Capital expenditures | $10000.00 | $10000.00 | $10000.00 | $10000.00 | $50000.00 | $6000.00 | $9000.00 | $13000.00 | $2000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $18000.00 | — | $89000.00 | $38000.00 | $812000.00 | $1.39M | $804000.00 | $310000.00 | $447000.00 |
| Free cash flow | $-880000.00 | $-645000.00 | $-619000.00 | $-2.57M | $-6.60M | $-6.46M | $-6.69M | $-12.63M | $-3.96M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |